7/4/2025CDE Solicits Comments on the 95th Batch of Reference Formulations for ...

7/4/2025CDE Seeks Comment on Revised eCTD Technical Documents and Mapping Tabl...

7/4/2025AstraZeneca Eyes $15B Deal for Summit's Chinese-Developed Lung Cancer ...

7/4/2025Legend Initiates First-in-Human Trial for LUCAR-G19 in Autoimmune Dise...

7/4/2025Brii Biosciences Taps Joincare Pharma to Drive BRII‑693 in Greater Ch...

7/4/2025Shaanxi Micot Secures 100M CNY in Series D Financing

7/3/2025Vaccine Sales Collapse in China as MNCs Struggle with Local Competitio...

7/3/2025AbbVie's Venclexta Approved in China for Second-Line Treatment of del1...

7/3/2025Eli Lilly's Tirzepatide Approved in China for Treatment of Obstructive...

7/3/2025Hengrui Medicine Gains NMPA Approval for Novel Dry Eye Treatment SHR80...

7/3/2025CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding Disorders

More>>

7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...

7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)

7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...

7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...

7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...

6/27/2025Analyzing Key Trends in China's Patent-Linkage System and Their Impact...

6/27/2025Fresh Antitrust Guidelines to Address Pharmaceutical Monopoly Issues i...

6/25/2025Breaking the Boundaries: A New Map of Physician Behavior in China's Di...

6/19/2025Structuring Cross Border China Biotech 'NewCo' Transactions (Life Scie...

6/19/2025CDE Annual Report Reveals Strong Growth and Evolving Focus in China's ...

6/17/2025China Emerges as Prime Global Target for Multinationals in Biotech Dea...

More>>